Suchergebnisse - "Safadi, Rifaat"

PubPharm (207)

1

Low ALT Is Associated with IBD and Disease Activity : Results from a Nationwide Study

enthalten in: Journal of clinical medicine | 2024

von Shafrir, A. | Katz, L. | Shauly-Aharonov, M. | +4

2

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Hirschfield, G. | Bowlus, C. | Mayo, M. | +94

3

TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

enthalten in: Harefuah | 2024

von Milgrom, Y. | Massarwa, M. | Hazou, W. | +5

4

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

enthalten in: The New England journal of medicine | 2024

von Harrison, S. | Bedossa, P. | Guy, C. | +127

5

The liver in Greco-Arabic and Islamic medicine

enthalten in: Clinical liver disease | 2024

von Safadi, R.

6

Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis

enthalten in: Vaccine: X | 2023

von Hakimian, D. | Amer, J. | Jammal, A. | +9

7

PEPTIDE MODULATORS OF NEUROLIGIN 4-NEUREXIN 1-BETA AXIS FOR TREATMENT OF LIVER DISORDERS

enthalten in: Europäisches Patentamt | 2023

von SAFADI RIFAAT | AMER JOHNNY

8

PEPTIDE MODULATORS OF NEUROLIGIN 4-NEUREXIN 1-BETA AXIS FOR TREATMENT OF LIVER DISORDERS

enthalten in: Europäisches Patentamt | 2023

von SAFADI RIFAAT | AMER JOHNNY

9

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

enthalten in: Journal of hepatology | 2023

von Razavi, H. | Buti, M. | Terrault, N. | +89

10

Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders

enthalten in: Europäisches Patentamt | 2023

von SAFADI RIFAAT

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]